Unlike Elon Musk's PR strategy with Neuralink, China uses a systemic state approach. BCI technologies are already included in pilot medical insurance (reimbursement) schemes, providing a guaranteed market. Integrating LLM agents with neuroimplants will not only treat severe neurological diseases but also create a new class of controllers for industrial robotics. China is investing in wetware (the merging of biology and software) with the same aggression it used to build battery factories.
Source: Reuters / TechCrunch
BioTechBCIChinaNeuroscienceWetware